Literature DB >> 26718845

Risk factor analysis of bone resorption following secondary alveolar bone grafting using three-dimensional computed tomography.

Tae Suk Oh1, Joo Seok Park1, Jong Woo Choi1, Soon Man Kwon2, Kyung S Koh3.   

Abstract

BACKGROUND/AIM: The purpose of this study is to analyze the risk factors for bone resorption following secondary bone grafting in the alveolar cleft, using three-dimensional (3D) computed tomography (CT) based on surgical simulation software (SimPlant OMS, Materialise Dental, Leuven, Belgium).
METHODS: We reviewed the secondary alveolar bone grafts performed by a single surgeon between January 2005 and January 2014. A total of 40 patients with unilateral alveolar cleft were included in this study. The grafted alveolar bone was measured using surgical simulation software. In order to validate the measurement, each data set was measured by three different analysts and the inter- and intraobserver variabilities were calculated. A total of eight risk factors for grafted bone survival, including patient age, sex, body mass index (BMI), palatal fistula, amount of grafted bone, dental appliance, canine or incisor eruption, and preoperative upper respiratory tract infection, were evaluated using the linear mixed model and Mann-Whitney test.
RESULTS: The average alveolar defect size was 4.98 cc and the average graft survival was 67.5%. The inter- and intraobserver variabilities of simulation software were 0.758 and 0.915, respectively. Among the risk factors, only dental appliance (p = 0.02) and canine eruption (p = 0.041) were significantly correlated with graft survival. Other risk factors, including the amount of grafted bone, did not show a significant relationship with graft survival.
CONCLUSION: Measurement of an alveolar bone defect using a simulation program based on 3D CT is reliable and reproducible. Secondary bone grafting survival was significantly correlated with canine eruption and dental appliance in the alveolar cleft.
Copyright © 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alveolar bone grafting; Bone transplantation; Cone beam computed tomography; Three-dimensional image

Mesh:

Year:  2015        PMID: 26718845     DOI: 10.1016/j.bjps.2015.11.002

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

1.  Correlation between alveolar cleft morphology and the outcome of secondary alveolar bone grafting for unilateral cleft lip and palate.

Authors:  Xinlei Yu; Yiping Huang; Weiran Li
Journal:  BMC Oral Health       Date:  2022-06-22       Impact factor: 3.747

2.  Pilot study of factors contributing to canine impaction after secondary alveolar bone grafting in unilateral cleft lip and palate patients.

Authors:  Yoko Tsurumi; Kazuaki Nishimura; Megumi Shimizu; Yoshimichi Imai; Kaoru Igarashi
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

3.  Localized tissue mineralization regulated by bone remodelling: A computational approach.

Authors:  Marcelo Berli; Carlos Borau; Oscar Decco; George Adams; Richard B Cook; José Manuel García Aznar; Peter Zioupos
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

4.  Alveolar bone heights of maxillary central incisors in unilateral cleft lip and palate patients using cone-beam computed tomography evaluation.

Authors:  Marcin Stasiak; Anna Wojtaszek-Słomińska; Bogna Racka-Pilszak
Journal:  J Orofac Orthop       Date:  2021-02-05       Impact factor: 1.938

5.  An optimized imaging protocol for orofacial cleft patients.

Authors:  Dries De Mulder; Maria Cadenas de Llano-Pérula; Guy Willems; Reinhilde Jacobs; Jakob Titiaan Dormaar; Anna Verdonck
Journal:  Clin Exp Dent Res       Date:  2018-07-25

6.  CBCT in orthodontics: a systematic review on justification of CBCT in a paediatric population prior to orthodontic treatment.

Authors:  Annelore De Grauwe; Irem Ayaz; Sohaib Shujaat; Simon Dimitrov; Logan Gbadegbegnon; Bart Vande Vannet; Reinhilde Jacobs
Journal:  Eur J Orthod       Date:  2019-08-08       Impact factor: 3.075

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.